Aerosol formulation for pulmonary administration or diisobutyryl apomorphine, leuprolide acetate or analogues to produce a systemic effect
PK139953AUndetermined Publication Date: 2009-01-30CHIESI FARMACEUTICI SPA
0 Cites 0 Cited by
Patent Information
- Application Number
- PK200300157
- Authority / Receiving Office
- PK · PK
- Patent Type
- Applications
- Current Assignee / Owner
- Publication Date
- 2009-01-30
Abstract
The invention discloses an aerosol pharmaceutical composition comprising a medicament in solution in a mixture of a hydrofluoroalkane propellant and one or more co-solvents wherein the aerosol liquid droplets delivered on actuation of the inhaler have a particle size comprised between 0.5 um and 2.5 µm, with a mass median aerodynamic diameter of about 1-2 µm and wherein the fine particle fraction is at least 30%.
Need to check novelty before this filing date? Find Prior Art
